Dashboard
Manage Tickers

UNCYUnicycive Therapeutics, Inc.

Nasdaq unicycive.com


$ 1.09 $ 0.05 (4.63 %)    

Friday, 10-May-2024 15:28:52 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 1.13
$ 1.06
$ 0.00 x 0
$ 0.00 x 0
$ 1.06 - $ 1.09
$ 0.47 - $ 1.82
273,187
na
39.27M
$ -2.22
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-28-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-16-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 11-11-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

benchmark-reiterates-speculative-buy-on-unicycive-therapeutics-maintains-3-price-target
Benchmark Reiterates Speculative Buy on Un...
04/15/2024 15:00:32

Benchmark analyst Bruce Jackson reiterates Unicycive Therapeutics (NASDAQ:UNCY) with a Speculative Buy and maintains $3 pric...

piper-sandler-initiates-coverage-on-unicycive-therapeutics-with-overweight-rating-announces-price-target-of-9
Piper Sandler Initiates Coverage On Unicyc...
04/04/2024 11:03:54

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Unicycive Therapeutics (NASDAQ:UNCY) with a Overweight rating and...

correction-on-friday-unicycive-therapeutics-reported-q4-eps-of-022-which-missed-017-estimate
CORRECTION: On Friday, Unicycive Therapeut...
04/01/2024 11:04:09

Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate...

hc-wainwright--co-reiterates-buy-on-unicycive-therapeutics-maintains-45-price-target
HC Wainwright & Co. Reiterates Buy on Unic...
04/01/2024 10:16:15

HC Wainwright & Co. analyst Ed Arce reiterates Unicycive Therapeutics (NASDAQ:UNCY) with a Buy and maintains $4.5 price ...

why-limbach-holdings-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Limbach Holdings Shares Are Trading Lo...
03/14/2024 17:38:41

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarte...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
03/14/2024 13:06:15

unicycive-therapeutics-announced-it-has-entered-into-a-securities-purchase-agreement-with-certain-healthcare-focused-institutional-investors-for-the-sale-of-50000-shares-of-its-series-b-convertible-preferred-stock-at-an-offering-price-of-1000-per-share
Unicycive Therapeutics Announced It Has En...
03/14/2024 11:10:43

hc-wainwright--co-reiterates-buy-on-unicycive-therapeutics-maintains-45-price-target
HC Wainwright & Co. Reiterates Buy on Unic...
03/14/2024 10:48:24

HC Wainwright & Co. analyst Ed Arce reiterates Unicycive Therapeutics (NASDAQ:UNCY) with a Buy and maintains $4.5 price ...

hc-wainwright--co-reiterates-buy-on-unicycive-therapeutics-maintains-45-price-target
HC Wainwright & Co. Reiterates Buy on Unic...
03/08/2024 12:16:31

HC Wainwright & Co. analyst Ed Arce reiterates Unicycive Therapeutics (NASDAQ:UNCY) with a Buy and maintains $4.5 price ...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
03/07/2024 21:31:03

unicycive-therapeutics-completes-enrollment-in-pivotal-clinical-trial-for-oxylanthanum-carbonate
Unicycive Therapeutics Completes Enrollmen...
03/07/2024 21:12:54

hc-wainwright--co-reiterates-buy-on-unicycive-therapeutics-maintains-45-price-target
HC Wainwright & Co. Reiterates Buy on Unic...
03/05/2024 12:06:10

HC Wainwright & Co. analyst Ed Arce reiterates Unicycive Therapeutics (NASDAQ:UNCY) with a Buy and maintains $4.5 price ...

unicycive-therapeutics-announces-orphan-drug-designation-granted-for-uni-494-by-the-us-food-and-drug-administration-for-the-prevention-of-delayed-graft-function-in-kidney-transplant-patients
Unicycive Therapeutics Announces Orphan Dr...
03/04/2024 12:05:52

Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidne...

noble-capital-markets-initiates-coverage-on-unicycive-therapeutics-with-outperform-rating-announces-price-target-of-6
Noble Capital Markets Initiates Coverage O...
02/14/2024 17:50:04

Noble Capital Markets analyst Robert LeBoyer initiates coverage on Unicycive Therapeutics (NASDAQ:UNCY) with a Outperform ra...

unicycive-therapeutics-announced-that-two-posters-related-to-the-companys-lead-product-candidate-oxylanthanum-carbonate-will-be-presented-at-the-national-kidney-foundation-spring-clinical-meeting-taking-place-may-14-18
Unicycive Therapeutics Announced That Two ...
02/14/2024 12:28:25

why-3m-shares-are-trading-lower-by-over-12-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why 3M Shares Are Trading Lower By Over 12...
01/23/2024 19:37:34

Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-q...

unicycive-therapeutics-issues-shareholder-letter-to-highlight-corporate-progress-key-upcoming-milestones-says-topline-data-from-oxylanthanum-carbonate-olc-pivotal-trial-expected-in-q2-2024
Unicycive Therapeutics Issues Shareholder ...
01/23/2024 12:08:08

why-coherus-biosciences-shares-are-trading-higher-by-22-here-are-20-stocks-moving-premarket
Why Coherus BioSciences Shares Are Trading...
01/22/2024 13:21:24

Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announc...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
01/11/2024 21:31:17

hc-wainwright--co-reiterates-buy-on-unicycive-therapeutics-maintains-45-price-target
HC Wainwright & Co. Reiterates Buy on Unic...
12/19/2023 11:27:35

HC Wainwright & Co. analyst Ed Arce reiterates Unicycive Therapeutics (NASDAQ:UNCY) with a Buy and maintains $4.5 price ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION